UNSPSC 51332517: Cloroperone hydrochloride

This classification denotes an anxiolytic with the molecular formula C22H23ClFNO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95U4NV3X82, chemically known as 1-butanone, 4-(4-(4-chlorobenzoyl)-1-piperidinyl)-1-(4-fluorophenyl)-, hydrochloride but more generally known as cloroperone hydrochloride, which bears US NIH Compound Identifier 41535. Most nations, for tariff and trade purposes, schedule cloroperone hydrochloride under HS 29333999 and SITC 51574.

As of Q4 2014, CLOROPERONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Cloroperone hydrochloride bears US NLM identifiers UMLS ID C2347810 and NCI Concept Code C72728. SMILES: C1CC(CCC1C(=O)CCCN2CCC(CC2)C(=O)C3CCC(CC3)CL)F.CL.

UNSPSC 51332517 Cloroperone hydrochloride is a Commodity code that does not appear to match the work actually being solicited under it in recent state and local opportunities. The source contains three recent opportunities tagged to this code: a Seminole County, Florida competitive bid for naloxone and drug deactivation systems; a Texas Health and Human Services Commission Request for Information on direct-to-manufacturer pharmacy programs; and a Minnesota Multistate Cooperative Purchasing Alliance RFP for generic pharmaceuticals and OTC products. None of these solicitations involve cloroperone hydrochloride procurement. The mismatch between the code's nominal scope and the actual recent opportunities suggests that this code shows little relevant recent activity at the state and local level, or that the opportunities have been miscoded in the source system.

The three posted opportunities do reflect broader state and local demand for pharmaceutical supply, naloxone distribution, and cooperative purchasing vehicles for medication procurement across multiple jurisdictions, but they do not directly support a summary of cloroperone hydrochloride procurement patterns. State and local procurement professionals evaluating this code should verify with issuing bodies whether cloroperone hydrochloride itself is being bought under UNSPSC 51332517, or whether the code in question should be reassigned to a different pharmaceutical product family before investing business development effort.